Epilepsy
Investigators in Italy, Brazil and Taiwan publish new epilepsy data
Published in Medical Device Law Weekly, December 31st, 2006
Study 1: Fresh data on epilepsy are presented in the report "Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients." According to a study from Ancona, Italy, "Vagus nerve stimulation (VNS) is an effective alternative treatment for patients with partial refractory epilepsy. Nevertheless, information regarding VNS in children is still limited. The clinical efficacy, safety and neuropsychological effects of VNS in 34 children (mean age 11.5 years) with drug-resistant epilepsy were studied."
"Mean follow-up was 30.8 months. Nine patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Alcohol Use
Alcohol monitor achieves milestones in fight against alcohol abuse - Business Update
NDSI Healthcare, Sandata to integrate home health software and telephony technology - Finance
Angiotech Pharmaceuticals proposes offering of senior floating rate notes due 2013 - Finance
LCA-Vision completes share repurchase plan, announces new share plan, increases dividend - Healthcare Access
Mcare Commission report focuses on ensuring access to quality healthcare for Pennsylvanians - Legal Issues
Court denies Medtronic motion in Implantable Cardioverter Defibrillator lawsuits - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
